News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,231 Results
Type
Article (51927)
Company Profile (378)
Press Release (684926)
Section
Business (216304)
Career Advice (2145)
Deals (37008)
Drug Delivery (97)
Drug Development (84057)
Employer Resources (173)
FDA (17066)
Job Trends (15914)
News (364607)
Policy (35016)
Tag
Academia (2833)
Alliances (53102)
Alzheimer's disease (1278)
Approvals (16978)
Artificial intelligence (141)
Bankruptcy (366)
Best Places to Work (12085)
Biotechnology (266)
Breast cancer (114)
Cancer (978)
Cardiovascular disease (89)
Career advice (1803)
Cell therapy (223)
Clinical research (66246)
Collaboration (350)
Compensation (174)
COVID-19 (2695)
C-suite (89)
Data (918)
Diabetes (141)
Diagnostics (6456)
Earnings (87194)
Employer resources (152)
Events (116467)
Executive appointments (265)
FDA (17531)
Funding (308)
Gene therapy (162)
GLP-1 (623)
Government (4639)
Healthcare (19981)
Infectious disease (2774)
Inflammatory bowel disease (107)
Interviews (324)
IPO (16815)
Job creations (4151)
Job search strategy (1547)
Layoffs (437)
Legal (8528)
Lung cancer (163)
Manufacturing (164)
Medical device (14244)
Medtech (14249)
Mergers & acquisitions (20216)
Metabolic disorders (401)
Neuroscience (1534)
NextGen Class of 2024 (7067)
Non-profit (4791)
Northern California (1255)
Obesity (240)
Opinion (199)
Patents (101)
People (60105)
Phase I (20632)
Phase II (29090)
Phase III (21722)
Pipeline (220)
Postmarket research (2745)
Preclinical (8908)
Radiopharmaceuticals (253)
Rare diseases (197)
Real estate (6474)
Regulatory (23105)
Research institute (2537)
Resumes & cover letters (370)
Southern California (1127)
Startups (3952)
United States (12402)
Vaccines (593)
Weight loss (189)
Date
Today (201)
Last 7 days (889)
Last 30 days (3216)
Last 365 days (37077)
2024 (31987)
2023 (41664)
2022 (53018)
2021 (57741)
2020 (56600)
2019 (49658)
2018 (37585)
2017 (34495)
2016 (34457)
2015 (40574)
2014 (34256)
2013 (29541)
2012 (31878)
2011 (32510)
2010 (30890)
Location
Africa (814)
Arizona (204)
Asia (41604)
Australia (6961)
California (2871)
Canada (1197)
China (221)
Colorado (128)
Connecticut (133)
Europe (91381)
Florida (408)
Georgia (110)
Illinois (344)
Indiana (188)
Kansas (100)
Maryland (557)
Massachusetts (2394)
Michigan (160)
Minnesota (265)
New Jersey (867)
New York (870)
North Carolina (736)
Northern California (1255)
Ohio (129)
Pennsylvania (772)
South America (1218)
Southern California (1127)
Texas (410)
Utah (86)
Washington State (345)
737,231 Results for "otonexus medical technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioForest
OtoNexus Medical Technologies Accepted into Prestigious Pediatric Medical Device Accelerator, CTIP
OtoNexus Medical Technologies Inc., is proud to announce its recent acceptance into The Consortium for Technology & Innovation in Pediatrics (CTIP).
December 12, 2023
·
2 min read
BioForest
OtoNexus Medical Technologies Selected for Elite FDA STeP Program
OtoNexus Medical Technologies is excited to announce its recent selection into U. S. Food and Drug Administration Safter Technologies Program (STeP).
December 6, 2023
·
2 min read
BioForest
OtoNexus Medical Technologies Honored as a Top 100 Best Place to Work in Washington State
OtoNexus Medical Technologies, a medical device innovator, is celebrating its recognition as one of Washington’s 100 Best Workplaces.
June 28, 2023
·
2 min read
Business
OtoNexus Medical Technologies Welcomes Chris Rivera to its Board of Directors
OtoNexus Medical Technologies, Inc. is pleased to announce the appointment of Chris Rivera to its Board of Directors.
April 4, 2023
·
2 min read
Business
GT Medical Technologies, Inc. Appoints Two Industry Medical Device Veterans to Key Leadership Positions
GT Medical Technologies, Inc. today announced two significant additions to its leadership team: Tom Moore as Chief Commercial Officer and Sandeep Yadav as Chief Financial Officer.
June 20, 2024
·
2 min read
News
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
October 18, 2024
·
1 min read
Pharm Country
Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference 2024
Helius Medical Technologies, Inc. announced that it will participate in the Spring MicroCap Rodeo Conference to be held on Thursday, June 6th in NYC.
May 31, 2024
·
6 min read
Pharm Country
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
Helius Medical Technologies, Inc. announced the completion of site participation enrollment for its stroke registrational program in the U.S. with the addition of REHABOLOGYM, Neurology Center of New England, and MGH Institute of Health Professions.
June 17, 2024
·
10 min read
Business
Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results
Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced results for the quarter ended March 31, 2024.
May 13, 2024
·
10 min read
Deals
GT Medical Technologies, Inc. Completes Strategic Acquisition of Radioactive Seed Assets from Perspective Therapeutics, Inc.
GT Medical Technologies, Inc. (GT MedTech) announces the successful acquisition of Cesium-131 and related assets from Isoray Medical, a subsidiary of Perspective Therapeutics, Inc.
April 15, 2024
·
5 min read
1 of 73,724
Next
